FDA approve meds
![]() | FDA provisionally holds the approval of Pozen’s meds - The hold on the combination drug of aspirin by the FDA agency, which has been manufactured by the company Pozen despite being carried out a positive phase II trial, has shocked the company. All eyes are on the further in vivo bioequivalence study in this regard, which may lead to approval of the drug. » By Balfour Morris, created on Jul. 24 2012 In Press Releases and Company Profiles |